BEAM
Beam Therapeutics Inc.
26.43
USD
This page is just a preview of the data found in TrendSpider’s full version
Beam Therapeutics Inc. stock is up 19.27% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 December’s closed higher than November. In the last 6 Unusual Options Trades, there were 1 PUT, 5 CALLs. 0% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 20 Oct 16:18 | 19 Jan, 2024 | 25.00 | 271 | ||
| 31 Oct 17:09 | 15 Dec, 2023 | 20.00 | 61 | ||
| 03 Nov 17:20 | 16 Feb, 2024 | 25.00 | 251 | ||
| 07 Nov 15:24 | 17 May, 2024 | 30.00 | 504 | ||
| 21 Nov 14:53 | 16 Feb, 2024 | 30.00 | 199 | ||
| 21 Nov 15:48 | 16 Feb, 2024 | 30.00 | 199 |
Beam Therapeutics Inc. develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders.
